ENDPOINTS

Ophthalmology startup Character Biosciences gets $93M for genetics-based approach

Seven years into its existence, Character Biosciences is ready to enter the clinic with a pair of experimental medicines targeting a bustling area of ophthalmology. The New Jersey biotech aims to treat age-related macular degeneration ...

Mar 25, 2025 - 13:03
 0
Ophthalmology startup Character Biosciences gets $93M for genetics-based approach
Seven years into its existence, Character Biosciences is ready to enter the clinic with a pair of experimental medicines targeting a bustling area of ophthalmology. The New Jersey biotech aims to treat age-related macular degeneration ...
Read More

Tags:

Previous Article

Nuclear Fusion Requires Certain Fuel, and Researchers Have Found a Greener Way t...

Next Article

‘Protect our future’: Alaskan Indigenous town fights ‘destructive’ uranium mine ...

Related Posts

Avidity heads to FDA with exon 44 skipping Duchenne muscular dystrophy drug

Avidity heads to FDA with exon 44 skipping Duchenne mus...

Mar 17, 2025  0

Start of 2025 comes with generic drug price decreases, several major increases, report finds

Start of 2025 comes with generic drug price decreases, ...

Mar 7, 2025  0

Sorriso Pharmaceuticals outlines Phase 1b ulcerative colitis data for oral antibody

Sorriso Pharmaceuticals outlines Phase 1b ulcerative co...

Feb 27, 2025  0